Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147 JPY | -0.68% | +1.38% | -10.91% |
04-10 | Healios Partners with AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen | MT |
04-09 | Healios K.K. Enters into Joint Research Agreement with AND Medical Group | CI |
Sales 2024 * | 910M 5.74M 460M | Sales 2025 * | 1.38B 8.69M 696M | Capitalization | 13.25B 83.64M 6.7B |
---|---|---|---|---|---|
Net income 2024 * | -2.69B -16.99M -1.36B | Net income 2025 * | -2.41B -15.23M -1.22B | EV / Sales 2024 * | 13.7 x |
Net cash position 2024 * | 822M 5.19M 416M | Net Debt 2025 * | 608M 3.84M 307M | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
-4.43
x | P/E ratio 2025 * |
-4.81
x | Employees | 64 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.9% |
1 day | -0.68% | ||
1 week | +1.38% | ||
Current month | -8.70% | ||
1 month | +2.80% | ||
3 months | +1.38% | ||
6 months | -6.37% | ||
Current year | -10.91% |
Managers | Title | Age | Since |
---|---|---|---|
Hardy Kagimoto
CEO | Chief Executive Officer | 47 | 23/02/11 |
Richard Kincaid
DFI | Director of Finance/CFO | 47 | 28/02/18 |
Masanori Sawada
CTO | Chief Tech/Sci/R&D Officer | 42 | 31/03/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 31/12/12 | |
Director/Board Member | 71 | 28/02/18 | |
Hardy Kagimoto
CEO | Chief Executive Officer | 47 | 23/02/11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 147 | -0.68% | 435,700 |
25/04/24 | 148 | -2.63% | 437,500 |
24/04/24 | 152 | -0.65% | 511,900 |
23/04/24 | 153 | +4.79% | 1,341,200 |
22/04/24 | 146 | +0.69% | 455,400 |
Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.91% | 84.17M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 4593 Stock